Thrombomodulin and Thrombopoietin, Two Biomarkers of Hemostasis, Are Positively Associated with Adherence to the World Cancer Research Fund/American Institute for Cancer Research Recommendations for Cancer Prevention in a Population-Based...

Overview

Journal Nutrients

Date 2019 Sep 6

PMID 31484340

Citations 3

Authors

Mirja Grafetstatter

Laura Pletsch-Borba

Disorn Sookthai

Nena Karavasiloglou

Theron Johnson

Verena A Katzke

Michael Hoffmeister

Peter Bugert

Rudolf Kaaks

Tilman Kuhn

Affiliations

Soon will be listed here.

Abstract

A pro-coagulative state is related to increased risk of cardiovascular diseases but also certain cancers. Since experimental and smaller human studies suggest that diet, physical activity, and body weight may all affect coagulation, we evaluated associations between these lifestyle factors and hemostatic biomarkers in a population-based study. Cross-sectional baseline data from 2267 randomly selected participants of EPIC-Heidelberg (age range 35-65 years) was used. Fibrinogen, glycoprotein IIb/IIIa, P-selectin, thrombomodulin (TM), and thrombopoietin (TPO) were measured in baseline plasma samples. A score reflecting adherence to the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations for cancer prevention was created. Associations between the WCRF/AICR score as well as its individual components and hemostatic biomarkers were analyzed by linear regression models. Multivariable-adjusted geometric means (95% confidence intervals) of TM and TPO were higher with greater adherence to the WCRF/AICR recommendations (TM, lowest vs. highest score category: 2.90 (2.7,3.1) vs. 3.10 (2.9,3.3) ng/mL, = 0.0001; TPO: 328 (302,356) vs. 348 (321,378) pg/mL, = 0.0007). These associations were driven by lower alcohol and meat consumption among persons with higher WCRF/AICR scores. Our results indicate that lifestyle factors favorably affect TM and TPO, two hemostatic factors implicated in chronic disease development.

Citing Articles

Modified WCRF/AICR Score and All-Cause, Digestive System, Cardiovascular, Cancer and Other-Cause-Related Mortality: A Competing Risk Analysis of Two Cohort Studies Conducted in Southern Italy.

Mirizzi A, Aballay L, Misciagna G, Caruso M, Bonfiglio C, Sorino P Nutrients. 2021; 13(11).

PMID: 34836259 PMC: 8620807. DOI: 10.3390/nu13114002.

Comparison of four healthy lifestyle scores for predicting cardiovascular events in a national cohort study.

Tsai M, Yeh T, Hsu H, Hsu L, Lee C, Tseng P Sci Rep. 2021; 11(1):22146.

PMID: 34772956 PMC: 8589956. DOI: 10.1038/s41598-021-01213-6.

SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.

Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A Cancers (Basel). 2020; 12(11).

PMID: 33182653 PMC: 7697868. DOI: 10.3390/cancers12113316.

References

Hoting I, Boeing H, Wahrendorf J . Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997; 26 Suppl 1:S59-70. DOI: 10.1093/ije/26.suppl_1.s59. View

Senaran H, Ileri M, Altinbas A, Kosar A, Yetkin E, Ozturk M . Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol. 2001; 24(5):405-8. PMC: 6655056. DOI: 10.1002/clc.4960240511. View

Kaptoge S, White I, Thompson S, Wood A, Lewington S, Lowe G . Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies.... Am J Epidemiol. 2007; 166(8):867-79. DOI: 10.1093/aje/kwm191. View

Gremmel T, Frelinger 3rd A, Michelson A . Platelet Physiology. Semin Thromb Hemost. 2016; 42(3):191-204. DOI: 10.1055/s-0035-1564835. View

Rimm E, Williams P, Fosher K, Criqui M, Stampfer M . Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319(7224):1523-8. PMC: 28294. DOI: 10.1136/bmj.319.7224.1523. View

Danesh J, Collins R, Appleby P, Peto R . Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998; 279(18):1477-82. DOI: 10.1001/jama.279.18.1477. View

Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F . Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A. 2012; 109(32):E2165-72. PMC: 3420192. DOI: 10.1073/pnas.1209182109. View

Folman C, Linthorst G, van Mourik J, van Willigen G, de Jonge E, Levi M . Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?. Thromb Haemost. 2000; 83(6):923-30. View

Boeing H, Korfmann A, Bergmann M . Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999; 43(4):205-15. DOI: 10.1159/000012787. View

10.

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

11.

Thorand B, Baumert J, Herder C, Meisinger C, Koenig W . Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-1998. Diabetologia. 2006; 50(3):545-8. DOI: 10.1007/s00125-006-0568-x. View

12.

Lupia E, Bosco O, Goffi A, Poletto C, Locatelli S, Spatola T . Thrombopoietin contributes to enhanced platelet activation in cigarette smokers. Atherosclerosis. 2009; 210(1):314-9. DOI: 10.1016/j.atherosclerosis.2009.11.019. View

13.

Mosesson M . Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005; 3(8):1894-904. DOI: 10.1111/j.1538-7836.2005.01365.x. View

14.

Zhu Y, Wei Y, Zhang R, Dong X, Shen S, Zhao Y . Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019; 28(5):935-942. PMC: 7075698. DOI: 10.1158/1055-9965.EPI-18-0356. View

15.

Romaguera D, Vergnaud A, Peeters P, van Gils C, Chan D, Ferrari P . Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012; 96(1):150-63. DOI: 10.3945/ajcn.111.031674. View

16.

Ricci C, Wood A, Muller D, Gunter M, Agudo A, Boeing H . Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study. BMJ. 2018; 361:k934. PMC: 5972779. DOI: 10.1136/bmj.k934. View

17.

Graf M, Sookthai D, Johnson T, Schubel R, Gonzalez Maldonado S, Pletsch-Borba L . Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study. Int J Cancer. 2018; 143(11):2659-2667. DOI: 10.1002/ijc.31623. View

18.

Stone R, Nick A, McNeish I, Balkwill F, Han H, Bottsford-Miller J . Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012; 366(7):610-8. PMC: 3296780. DOI: 10.1056/NEJMoa1110352. View

19.

Boeing H, Wahrendorf J, Becker N . EPIC-Germany--A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999; 43(4):195-204. DOI: 10.1159/000012786. View

20.

Lindahl A, Boffa M, Abildgaard U . Increased plasma thrombomodulin in cancer patients. Thromb Haemost. 1993; 69(2):112-4. View